ARGENT CAPITAL MANAGEMENT LLC

Position in LGND — Ligand Pharmaceuticals Inc

CIK 1120926 ST LOUIS, MO

Position in LGND

as of Jun 30, 2026 · filed Jul 15, 2026 Compact

Position Value

$1,201,774

+$505,994 QoQ

Shares Held

3,802

+9.1% QoQ

Ownership

0.019%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#182

of 411 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ARGENT CAPITAL MANAGEMENT LLC holds $49,840,633 across 3 Biotechnology names. LGND ranks #2 (2.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JAZZ	Jazz Pharmaceuticals plc	200,072	$48,211,349
2	LGND	Ligand Pharmaceuticals Inc This page	3,802	$1,201,774
3	HALO	Halozyme Therapeutics, Inc.	5,462	$427,510

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,201,774	3,802	+9.1%	Shares	Sole	2026-07-15
2026-03-31	$695,780	3,485	—	Shares	Sole	2026-05-21
No filing history on record for this holder in this stock.